Denver, CO, United States of America

Raphael Bar-Or

This inventor holds 34 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Oxidation-Reduction Potential. Top assignees: Aytu Bioscience, Inc., Ampio Pharmaceuticals, Inc., Luoxis Diagnostics, Inc.. Active years: 1998-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raphael Bar-Or. Retrieved from https://idiyas.com/inventor/raphael-bar-or

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 

% Patents Active = 76.5

 

 

Average Co-Inventor Count = 2.6

ph-index = 11

Forward Citations = 332(Granted Patents)


Location History:

  • Englewood, CO (US) (1998)
  • Denver, CO (US) (2003 - 2022)

Company Filing History:


Years Active: 1998-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
N-Acetyl Kynurenine
T-Cell Mediated Diseases
Oxidation-Reduction Potential
Fertility Potential
Multiple Layer Gel
Oxidative Status
Diagnosis of Multiple Sclerosis
Signal Processing
Prognosing Skin Lesions
Test Device
Reader Device
Measurement Methods
34 patents (USPTO):Explore Patents

Title: Raphael Bar-Or: Pioneering Innovator in Denver, CO

Introduction:

Raphael Bar-Or, a visionary inventor based in Denver, CO, has made significant contributions to the world of technology through his relentless pursuit of innovation. With an impressive portfolio of 34 patents, Bar-Or's work focuses on cutting-edge treatments for various diseases, showcasing his commitment to improving healthcare.

Latest Patents:

Bar-Or's latest patents demonstrate his expertise in developing groundbreaking treatments. One notable invention involves the use of N-acetyl kynurenine (NAK) for treating T-cell mediated diseases, degenerative joint diseases, and diseases mediated by platelet activating factor (PAF). Another patent highlights his method of treating T-cell mediated diseases and inhibiting T-cell activation using specific diketopiperazines.

Career Highlights:

Throughout his career, Bar-Or has worked with esteemed companies such as Aytu Bioscience, Inc. and Ampio Pharmaceuticals, Inc., where he has played a pivotal role in driving innovation and shaping the future of healthcare. His dedication to advancing medical treatments has earned him recognition as a key figure in the field of biotechnology.

Collaborations:

Bar-Or has collaborated with accomplished professionals, including David Bar-Or and Leonard T Rael, who have contributed to the success of his projects. These collaborations have fostered a culture of creativity and excellence, leading to the development of cutting-edge solutions in healthcare.

Conclusion:

In conclusion, Raphael Bar-Or emerges as a pioneering inventor whose passion for innovation has had a profound impact on the field of technology. His groundbreaking inventions and collaborative spirit serve as a testament to his commitment to pushing the boundaries of what is possible. Bar-Or's legacy will undoubtedly inspire future generations of inventors to strive for excellence and drive positive change in the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…